Medpace Holdings, Inc.
Medpace Holdings, Inc. (MEDP) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · MEDP · as of Sep 30, 2025
Ownership Breakdown
689
Institutional Holders
▲ 73 vs Q2
$12.33B
Total Inst. Value
▲ $4.03B vs Q2
28.56M
Shares Outstanding
freeFloat 80.52%
23.97M
13F Shares Held
▼ 2.44M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
MEDP largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. services-commercial physical & biological research | 2.36M | 7.99% | 7.99% | $1.21T | Nov 12, 2025 | ▼ 107.6K |
VANGUARD GROUP INC services-commercial physical & biological research | 2.28M | 7.74% | 7.74% | $1.17T | Nov 7, 2025 | ▼ 107.7K |
AQR CAPITAL MANAGEMENT LLC services-commercial physical & biological research | 1.03M | 3.48% | 3.48% | $518.17B | Nov 14, 2025 | ▲ 404.2K |
WASATCH ADVISORS LP services-commercial physical & biological research | 926.0K | 3.14% | 3.14% | $476.09B | Nov 14, 2025 | ▼ 19.9K |
STATE STREET CORP services-commercial physical & biological research | 673.1K | 2.28% | 2.28% | $346.10B | Nov 14, 2025 | ▼ 33.6K |
MAWER INVESTMENT MANAGEMENT LTD. services-commercial physical & biological research | 646.8K | 2.19% | 2.19% | $332.55B | Nov 4, 2025 | ▼ 170.7K |
GEODE CAPITAL MANAGEMENT, LLC services-commercial physical & biological research | 642.7K | 2.18% | 2.18% | $330.47B | Nov 12, 2025 | ▲ 4.7K |
D. E. SHAW & CO., INC. services-commercial physical & biological research | 600.1K | 2.04% | 2.04% | $308.57B | Nov 14, 2025 | ▲ 256.6K |
BAILLIE GIFFORD & CO services-commercial physical & biological research | 584.8K | 1.98% | 1.98% | $300.68B | Oct 31, 2025 | ▲ 62.5K |
INVESCO LTD. services-commercial physical & biological research | 537.4K | 1.82% | 1.82% | $276.31B | Nov 13, 2025 | ▲ 85.5K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
19
Increased
+1.38M shares0
New Positions
first time holders30
Decreased
−2.40M shares0
Sold Out
fully exitedNet shares change (top 50)
1.02M
+1.38M / −2.40M
Net new holders
-11
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
MEDP insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
8
Buy transactions
9
Sell transactions
0.89
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
EWALD STEPHEN P General Counsel & Corp. Secy. | May 28, 2026 | Sale | 16,349 | $450.00 | $7.36M | 20.3K | Form 4 ↗ |
Zander Dani S. director | May 15, 2026 | Award | 1,110 | $415.27 | $460.9K | 1.1K | Form 4 ↗ |
McCarthy Cornelius P. III director | May 15, 2026 | Award | 1,110 | $415.27 | $460.9K | 1.1K | Form 4 ↗ |
Kraft Robert O. director | May 15, 2026 | Award | 1,110 | $415.27 | $460.9K | 1.1K | Form 4 ↗ |
Gwadry-Sridhar Femida H. director | May 15, 2026 | Award | 1,110 | $415.27 | $460.9K | 1.1K | Form 4 ↗ |
DAVENPORT FRED B JR director | May 15, 2026 | Award | 1,110 | $415.27 | $460.9K | 1.1K | Form 4 ↗ |
Carley Brian T director | May 15, 2026 | Award | 1,110 | $415.27 | $460.9K | 1.1K | Form 4 ↗ |
Troendle August J. CEO | Apr 24, 2026 | Award | 20,000 | $410.54 | $8.21M | 20.0K | Form 4 ↗ |
EWALD STEPHEN P General Counsel & Corp. Secy. | Apr 24, 2026 | Award | 10,000 | $410.54 | $4.11M | 10.0K | Form 4 ↗ |
BURWIG SUSAN E Exec. VP, Operations | Apr 24, 2026 | Award | 10,000 | $410.54 | $4.11M | 10.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Medpace Holdings, Inc. (MEDP) is primarily owned by institutional investors, who hold approximately 83.9% of total shares outstanding. Company insiders own approximately 19.48%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Medpace Holdings, Inc. is BLACKROCK, INC., holding approximately 2.36 million shares — equal to 7.99% of outstanding shares — as of September 30, 2025.
A total of 689 institutional investors currently hold MEDP stock, with a combined institutional value of approximately $12.33 billion as of the most recent 13F filing period.
Frequently asked questions
MEDP ownershipMedpace Holdings, Inc. (MEDP) is primarily owned by institutional investors, who hold approximately 83.9% of shares. The largest shareholder is BLACKROCK, INC. with a 7.99% stake. Company insiders hold 19.48%. Data sourced from SEC Form 13F as of September 30, 2025.